References
- Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499–511.
- Ahmed I, Thorpy M. Clinical features, diagnosis and treatment of narcolepsy. Clin Chest Med 2010;31:371–81.
- Dauvilliers Y, Montplaisir J, Cochen V, Desautels A, Einen M, Lin L, . PostH1N1 narcolepsy–cataplexy. Sleep 2010;22: 1428–30.
- World Health Organization. Global Advisory Committee on Vaccine Safety: Statement on narcolepsy and vaccination. Geneva: WHO; 2011. Available at: http://www.who.int/vaccine_safety/topics/influenza/pandemic/h1n1_safety_assessing/narcolepsy_february2011/en/ (accessed 23 March 2011).
- National Institute for Health and Welfare (THL) Finland. National narcolepsy task force interim report 31 January 2011. Helsinki, Finland: THL; 2011. Available at: http://www.thl.fi/thl-client/pdfs/dce182fb-651e-48a1-b018-3f774d6d1875 (accessed 20 March 2011).
- Morel S, Didierlaurent A, Bourguignon P, Delhaye S, Baras B, Jacob V, . Adjuvant system AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine 2011;29:2461–73.
- The Medical Dictionary for Regulatory Activities. MedDRA web-based browser version 2010.01.01. Available at: https://www.meddrabrowser.org/dsnavigator/ (accessed 15 March 2011).
- Dement W, Carskadon M, Ley R. The prevalence of narcolepsy II. Sleep Res 1973;2:147.
- Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze B, Besset A, . Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001;57:2029–33.
- Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39–40.
- Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, . A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991–7.
- Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, . Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469–74.
- Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, . Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010; 120:713–9.
- Hor H, Kutalik Z, Dauvilliers Y, Valsesia A, Lammers GJ, Donjacour CE, . Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010;42:786–90.
- Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, . Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009;41:708–11.
- Kornum BR, Kawashima M, Faraco J, Lin L, Rico TJ, Hesselson S, . Common variants in PYRY11 are associated with narcolepsy. Nat Genet 2011;43:66–71.
- Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted vaccines: integrated analysis from a large safety database. Vaccine 2009;27: 6959–65.